Navigation Links
Verenium Appoints Holger Liepmann To Its Board Of Directors
Date:2/26/2013

roducts, Verenium's dependence on manufacturing and/or license agreements,  its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies, the timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture or partnership agreements and licenses on a timely basis or at all, and risks and other uncertainties more fully described in Verenium's filings with the Securities and Exchange Commission, including, but not limited to, Verenium's annual report on Form 10-K for the year ended December 31, 2011 and any updates contained in its subsequently filed quarterly reports on Form 10-Q .  These forward-looking statements speak only as of the date hereof, and Verenium expressly disclaims any intent or obligation to update these forward-looking statements.

Contacts for Verenium:
Sarah Carmody
Sr. Corporate Communications Manager
858-431-8581
sarah.carmody@verenium.com


'/>"/>
SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
2. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
3. Verenium Announces $22.5 Million, Five-Year Secured Financing
4. Verenium Corporation To Announce Third Quarter 2012 Financial Results
5. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
6. Verenium Corporation To Announce Second Quarter 2012 Financial Results
7. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
8. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
9. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
10. Verenium Corporation To Announce First Quarter 2012 Financial Results
11. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... 2015 Optimal Research, LLC has been nominated ... Award "Best Clinical Site or Trial Network". ... been selected as a nominee in this ViE award ... Recommended" distinction in 2014. The ViE awards were created ... and positive contributions of companies and individuals in the ...
(Date:3/25/2015)... Laboratory workers can turn to ... Balances to get best-performing features while still remaining ... from the trusted brand include: , Cole-Parmer ... efficiency by providing a large weighing surface for ... include parts counting, percent weighing, checkweighing, animal/dynamic weighing, ...
(Date:3/25/2015)... March 25, 2015 An increase of ... in all forms of food nutrients, regulatory changes and ... substantial rise in demand for natural astaxanthin over the ... to ramp up their capacities to satisfy the rising ... and synthetic source astaxanthin (used in nutraceuticals, aqua feed, ...
(Date:3/25/2015)... Having added two International locations in Brisbane and ... Global proudly announced recently the organization’s expansion into Poland. ... in the United States, is one of the largest ... real estate. , Saltwood International is the ... advises occupiers of office space, ensuring that its corporate ...
Breaking Biology Technology:Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2International Organization Expands its Global Reach to Warsaw, Poland 2
... March 31 ImaRx Therapeutics, Inc., a,biopharmaceutical company developing ... update along with fourth,quarter and full year 2007 financial ... -- Initiated TUCSON Phase I/II clinical study ... trade name Kinlytic(TM) ...
... MANASQUAN, NJ., March 31 BioSpace, the world,s leading,online ... will host,the Biotech Beach(TM) Career in La Jolla, CA ... at the Hyatt Regency La Jolla from 2 pm-7 ... science professionals from across Southern California will attend,the biotech ...
... PharmAthene, Inc.,(Amex: PIP ) a biodefense ... today reported financial results for the,year ended December ... Chief Executive Officer commented, "In,2007 we continued to ... achieved a number of important milestones which included,obtaining ...
Cached Biology Technology:ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 2ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 3ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 4ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 5ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 6ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 7ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 8ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 9ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 10Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance 2PharmAthene Reports Year-End 2007 Financial Results 2PharmAthene Reports Year-End 2007 Financial Results 3PharmAthene Reports Year-End 2007 Financial Results 4PharmAthene Reports Year-End 2007 Financial Results 5PharmAthene Reports Year-End 2007 Financial Results 6PharmAthene Reports Year-End 2007 Financial Results 7PharmAthene Reports Year-End 2007 Financial Results 8PharmAthene Reports Year-End 2007 Financial Results 9
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... March 23, 2015   HOYOS Labs , a ... today announced that the Company will demonstrate multiple biometrics-based ... and consumers at Connect:ID on March 23 through 25, ... Labs will highlight the IEEE Biometric Open Protocol Standard; ... and enterprise access control system. BOPS was invented by ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ) ... Sensors Market Forecast and Opportunities 2020" report ... is projected to grow at a CAGR over ... industrial and healthcare sectors are the key application ... adoption of MEMS technology in sensors is growing ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... February 2, 2009 -- Over the past decade, two-thirds ... crop earlier because they believe that earlier planting increases ... important yet least expensive management decisions that significantly affects ... of early-planting dates on soybean yield components and the ...
... modern cancer treatment, but it,s not always effective. Successful ... escape from the bloodstream through the leaky blood vessels ... save thousands of individuals from unnecessary toxicity and the ... a study published in the February issue of the ...
... life plants, animals, people depends on peaceful coexistence ... from helping to convert food to energy to protection from ... uses a luminescent bacterium to create a predator-fooling light organ ... same species of bacteria like a flashlight to illuminate the ...
Cached Biology News:Plant soybean early to increase yield 2New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 2New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 3Single gene lets bacteria jump from host to host 2Single gene lets bacteria jump from host to host 3
... Mouse anti-Yersinia pestis F1 antigen, Monoclonal ... ELISA: Use at an ... an assay dependent dilution. WB: Use ... molecular weight: 18 kDa. Not tested ...
... medium is specifically formulated for mounting tissue ... been stained with immunohistochemical methods for viewing ... use with chromogens, such as AEC, that ... Faramount dries completely when slides are cover-slipped ...
... Vision Mount is formulated for covering tissue sections and cell ... insoluble end products. , ... Application: ... Fast-Red or AEC that require an aqueous mounting medium, or ...
... Product Rabbit polyclonal to JNK1 (phospho T183 ... to an internal domain containing phosphorylated T183/Y185. ... and Rat. Not yet tested in other species. ... several subgroups, including the ERK, JNK, and p38 ...
Biology Products: